Startup accelerator & VC Value proposition
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and MedtechOriginal language
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
https://www.kurmapartners.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Multeam Venture Capital and Private Equity Principals | Other 6 Dec 2021 | | |
 | Sygnature Discovery biotech, deeptech, Biotechnology Research | Capitalistic Partnership Not event 21 Nov 2017 | | |